Matchpoint Therapeutics, Matchpoint, Series B Financing, $150 Million, Financing, Nextech Invest, Norwest, MPT-062, T Cell Modulator, Autoimmune Diseases, Inflammatory Diseases,

WATERTOWN, Mass. — October 7, 2026 Matchpoint Therapeutics announced the successful closing of a $150 million Series B financing...